Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Malic Acid Spray for Xerostomia in Type 2 Diabetes
NCT04756986Unknown
- Start
- Jan 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in xerostomia comparing Malic Acid Group with Placebo Group (2 arms). Primary endpoint: Unstimulated salivary flow rate at 4 weeks. Status: unknown.
02
Drugs
malic acid
03
Conditions
xerostomia
Beyond the preview
Go deeper on NCT04756986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04756986.